293 related articles for article (PubMed ID: 18488219)
1. Combined modality immunotherapy and chemotherapy: a new perspective.
Ramakrishnan R; Antonia S; Gabrilovich DI
Cancer Immunol Immunother; 2008 Oct; 57(10):1523-9. PubMed ID: 18488219
[TBL] [Abstract][Full Text] [Related]
2. The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.
Hodge JW; Ardiani A; Farsaci B; Kwilas AR; Gameiro SR
Semin Oncol; 2012 Jun; 39(3):323-39. PubMed ID: 22595055
[TBL] [Abstract][Full Text] [Related]
3. On combining antineoplastic drugs with tumor vaccines.
Terando A; Mulé JJ
Cancer Immunol Immunother; 2003 Nov; 52(11):680-5. PubMed ID: 12955481
[No Abstract] [Full Text] [Related]
4. Combining cancer vaccines with chemotherapy.
Chong G; Morse MA
Expert Opin Pharmacother; 2005 Dec; 6(16):2813-20. PubMed ID: 16318432
[TBL] [Abstract][Full Text] [Related]
5. Enhancing efficacy of therapeutic vaccinations by combination with other modalities.
Gulley JL; Madan RA; Arlen PM
Vaccine; 2007 Sep; 25 Suppl 2(Suppl 2):B89-96. PubMed ID: 17573164
[TBL] [Abstract][Full Text] [Related]
6. Combinations of anticancer drugs and immunotherapy.
Mitchell MS
Cancer Immunol Immunother; 2003 Nov; 52(11):686-92. PubMed ID: 12942200
[TBL] [Abstract][Full Text] [Related]
7. Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer.
Kerr MD; McBride DA; Chumber AK; Shah NJ
Expert Opin Drug Discov; 2021 Jan; 16(1):89-99. PubMed ID: 32867561
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.
Ramakrishnan R; Gabrilovich DI
Cancer Immunol Immunother; 2011 Mar; 60(3):419-23. PubMed ID: 20976448
[TBL] [Abstract][Full Text] [Related]
9. The need for improvement of the treatment of advanced and metastatic cervical cancer, the rationale for combined chemo-immunotherapy.
van Meir H; Kenter GG; Burggraaf J; Kroep JR; Welters MJ; Melief CJ; van der Burg SH; van Poelgeest MI
Anticancer Agents Med Chem; 2014 Feb; 14(2):190-203. PubMed ID: 24237223
[TBL] [Abstract][Full Text] [Related]
10. Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy.
Collins JM; Redman JM; Gulley JL
Expert Rev Vaccines; 2018 Aug; 17(8):697-705. PubMed ID: 30058393
[TBL] [Abstract][Full Text] [Related]
11. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
Emens LA; Middleton G
Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
Baxevanis CN; Perez SA; Papamichail M
Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy: friend or foe to cancer vaccines?
Emens LA; Machiels JP; Reilly RT; Jaffee EM
Curr Opin Mol Ther; 2001 Feb; 3(1):77-84. PubMed ID: 11249735
[TBL] [Abstract][Full Text] [Related]
14. The potential beneficial effects of drugs on the immune response to vaccination.
Liu WM; Dalgleish AG
Semin Oncol; 2012 Jun; 39(3):340-7. PubMed ID: 22595056
[TBL] [Abstract][Full Text] [Related]
15. [Cancer immunotherapy: recent breakthroughs and perspectives].
Tartour E; Sandoval F; Bonnefoy JY; Fridman WH
Med Sci (Paris); 2011 Oct; 27(10):833-41. PubMed ID: 22027420
[TBL] [Abstract][Full Text] [Related]
16. Cancer vaccines: Enhanced immunogenic modulation through therapeutic combinations.
Gatti-Mays ME; Redman JM; Collins JM; Bilusic M
Hum Vaccin Immunother; 2017 Nov; 13(11):2561-2574. PubMed ID: 28857666
[TBL] [Abstract][Full Text] [Related]
17. A new era in anticancer peptide vaccines.
Perez SA; von Hofe E; Kallinteris NL; Gritzapis AD; Peoples GE; Papamichail M; Baxevanis CN
Cancer; 2010 May; 116(9):2071-80. PubMed ID: 20187092
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy Targeting WT1: Designing a Protocol for WT1 Peptide-Based Cancer Vaccine.
Nishida S; Sugiyama H
Methods Mol Biol; 2016; 1467():221-32. PubMed ID: 27417973
[TBL] [Abstract][Full Text] [Related]
19. Combination therapies utilizing neoepitope-targeted vaccines.
Lee KL; Schlom J; Hamilton DH
Cancer Immunol Immunother; 2021 Apr; 70(4):875-885. PubMed ID: 33033852
[TBL] [Abstract][Full Text] [Related]
20. Intratumoral Immunotherapy: From Trial Design to Clinical Practice.
Champiat S; Tselikas L; Farhane S; Raoult T; Texier M; Lanoy E; Massard C; Robert C; Ammari S; De Baère T; Marabelle A
Clin Cancer Res; 2021 Feb; 27(3):665-679. PubMed ID: 32943460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
